自和氧化应激调节介导前列腺癌中博特佐米布耐药性
Kalliopi Zafeiropoulou1,2, Georgios Kalampounias1, Spyridon Alexis2
1Division of Genetics, Cell Biology and Development, Department of Biology, University of Patras, Patras, Greece.
PloS one
|February 27, 2024
概括
癌症中的博特佐米布耐药性涉及自和改变的氧化应激. 了解这些机制可以改善各种癌症的蛋白酶体抑制剂疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 蛋白质酶抑制剂,如博尔特佐米布 (Bortezomib),对血液癌症有效.
- 对博尔特佐米布的耐药性限制了其治疗疗效,特别是在固体瘤和一些血液性恶性瘤中.
- 博尔特佐米布耐药性的机制尚未完全理解,这阻碍了更广泛的应用.
研究的目的:
- 建立一个抗博特佐米布的前列腺癌细胞系 (DU-145) 模型.
- 调查波尔特佐米布耐药性的潜在机制.
- 识别潜在的治疗点,以克服耐药性.
主要方法:
- 开发一种抗博尔特佐米布的DU-145细胞系.
- 评估蛋白质酶活性和促生存途径.
- 评估自诱导及其在蛋白质稳定中的作用.
- 测量反应性氧物种 (ROS) 的产生.
主要成果:
- 耐药细胞表现出恢复的蛋白酶活性,尽管存在Bortezomib.
- 诱导了自,补偿了蛋白酶体-泛素素系统.
- 与敏感细胞相比,耐药细胞表现出减少ROS生成.
- 在耐药克隆中激活了支持生存的途径.
结论:
- 自和氧化应激调节是博特佐米布耐药性的关键因素.
- 针对特定的信号通路和自可能会增强蛋白酶体抑制剂的有效性.
- 这些发现提供了潜在的策略来克服在癌症治疗中对博特佐米布的抗药性.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Electron Transport Chain: Complex I and II
13.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Delivery Pathways to the Lysosome
6.5K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.5K


